Julio Cirullo Neto

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background: Mutations in KRAS are negative predictors of the response to anti-EGFR therapies in the treatment of metastatic colorectal cancer. Yet, the ideal tissue to test for KRAS mutation-primary(More)
  • 1